LTC Properties and Sabra Health Care REIT are two prominent names in the healthcare REIT space, and both are in the middle of a similar strategic transformation. Each is shifting away from lower-growth triple-net leases toward directly operating seniors housing communities, where operators can capture stronger rent growth but also absorb more operating risk. This stock comparison is relevant for income-oriented investors weighing dividend reliability, as well as for traders evaluating relative momentum and market positioning. Because the two companies share a sector and a comparable strategy, their diverging execution and valuation make them a natural head-to-head pairing in the current market environment. I also checked this using Tickeron’s AI Screener to see how the stocks compare to others in the industry.
LTC (LTC Properties, Inc.) is a REIT focused on seniors housing and healthcare properties, investing through SHOP, triple-net leases, joint ventures, and structured finance. In recent weeks, the company has reported accelerating momentum in its SHOP segment, with total revenues rising sharply as resident fees are now booked on a gross basis. Acquisitions have run ahead of plan, prompting management to raise its full-year SHOP investment midpoint. The company also completed significant asset sales, generating gains and reshaping the portfolio toward a higher concentration of operating properties. Shares have gained roughly 24% year to date, suggesting investors have been rewarding the repositioning effort, though the earnings payoff is widely seen as weighted toward later years.
SBRA (Sabra Health Care REIT, Inc.) owns and finances healthcare real estate, including skilled nursing and transitional care facilities, seniors housing, behavioral health facilities, and specialty hospitals. Recent market activity has been driven by strong operating results in its SHOP portfolio, with same-store cash net operating income (NOI) growth in the mid-teens and margins described by management as best-in-class. The company has also re-tenanted a large property portfolio at materially higher rents and raised its full-year guidance at the midpoint. SBRA maintains a diversified, larger asset base and a dividend yield around 5.8%, while gradually increasing its SHOP concentration toward a targeted 40% by year-end and 50% by the end of 2027.
The two companies share a sector but differ in scale, diversification, and momentum. SBRA operates a larger and more varied portfolio — spanning skilled nursing, specialty hospitals, and behavioral health — which offers diversification but also exposes it to a broader range of regulatory and reimbursement risks. LTC is smaller and more concentrated in seniors housing, giving it a purer but less diversified bet on that recovery theme. On growth, both are scaling SHOP aggressively, but LTC's acquisition pace has consistently exceeded its own targets, while SBRA has leaned on strong same-store operating gains and rent resets. From a yield perspective, SBRA currently offers a higher dividend, while LTC has delivered the stronger recent price appreciation. Risk factors differ too: SBRA's leverage, measured as net debt to adjusted EBITDA, is moderate and declining, whereas LTC's shift toward operating assets introduces more operational variability in earnings.
On the basis of observable factors, Tickeron's AI would currently lean toward LTC. The tilt reflects LTC's more consistent upward price trend, its faster-than-planned execution on acquisitions, and the clearer catalyst path created by portfolio reshaping and asset-sale gains. SBRA presents a compelling income and diversification case, and its improving same-store metrics are notable, but its relative price momentum has been more measured in recent months. As always, the verdict is probabilistic rather than definitive: changing market conditions, interest-rate movements, or shifts in seniors housing fundamentals could narrow or reverse this positioning. Investors should treat the AI assessment as one analytical input among several. From what I see, reviewing the Trending AI Robots page helps put these relative strengths in a broader market context.
In my view, incorporating quantitative signals can sharpen a fundamentally driven comparison like this one. I often turn to Tickeron’s AI Daily Buy/Sell Signals to monitor how automated strategies are positioning in names like these, which adds a useful layer when evaluating momentum and catalysts alongside the balance sheet details.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
I’m a trader and independent researcher. My interest lies at the intersection of financial markets, algorithms, and capital management. I develop data-driven tools and strategies and study algorithmic approaches to market analysis. I help turn complex market data into clear insights and practical systems. I believe technology should support, not replace, investment thinking
LTC may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 22 of 32 cases where LTC's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 69%.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 4 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +2.64% 3-day Advance, the price is estimated to grow further. Considering data from situations where LTC advanced for three days, in 174 of 346 cases, the price rose further within the following month. The odds of a continued upward trend are 50%.
The Aroon Indicator entered an Uptrend today. In 101 of 287 cases where LTC Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 35%.
The 10-day RSI Indicator for LTC moved out of overbought territory on November 05, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 36 similar instances where the indicator moved out of overbought territory. In 22 of the 36 cases, the stock moved lower in the following days. This puts the odds of a move lower at 61%.
The Momentum Indicator moved below the 0 level on November 12, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on LTC as a result. In 37 of 88 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 42%.
The Moving Average Convergence Divergence Histogram (MACD) for LTC turned negative on November 11, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 47 similar instances when the indicator turned negative. In 20 of the 47 cases the stock turned lower in the days that followed. This puts the odds of success at 43%.
LTC moved below its 50-day moving average on November 16, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where LTC declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 42%.
The Tickeron Profit vs. Risk Rating rating for this company is 22 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 59, placing this stock better than average.
The Tickeron Price Growth Rating for this company is 46 (best 1 - 100 worst), indicating steady price growth. LTC’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 64 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 77 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.902) is normal, around the industry mean (3.134). P/E Ratio (15.932) is within average values for comparable stocks, (30.791). Projected Growth (PEG Ratio) (0.860) is also within normal values, averaging (1.649). Dividend Yield (0.017) settles around the average of (0.050) among similar stocks. P/S Ratio (6.057) is also within normal values, averaging (6.013).
The Tickeron PE Growth Rating for this company is 95 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a real estate investment trust
Industry PublishingBooksMagazines